
Karen C. Carlson
Examiner (ID: 14133, Phone: (571)272-0946 , Office: P/1656 )
| Most Active Art Unit | 1656 |
| Art Unit(s) | 1652, 1635, 1812, 1651, 1814, 1642, 1653, 1656, 1611, 1801 |
| Total Applications | 2193 |
| Issued Applications | 1462 |
| Pending Applications | 175 |
| Abandoned Applications | 558 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12509292
[patent_doc_number] => 10000549
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-19
[patent_title] => Compositions and methods for treatment of hematological malignancies
[patent_app_type] => utility
[patent_app_number] => 15/178085
[patent_app_country] => US
[patent_app_date] => 2016-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 26
[patent_no_of_words] => 11052
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15178085
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/178085 | Compositions and methods for treatment of hematological malignancies | Jun 8, 2016 | Issued |
Array
(
[id] => 12098247
[patent_doc_number] => 09855330
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-02
[patent_title] => 'Granulysin in immunotherapy'
[patent_app_type] => utility
[patent_app_number] => 15/174402
[patent_app_country] => US
[patent_app_date] => 2016-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 29
[patent_no_of_words] => 30336
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15174402
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/174402 | Granulysin in immunotherapy | Jun 5, 2016 | Issued |
Array
(
[id] => 13493635
[patent_doc_number] => 20180298360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => CAS9 VARIANTS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/574030
[patent_app_country] => US
[patent_app_date] => 2016-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 98668
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15574030
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/574030 | Cas9 variants and methods of use thereof | May 31, 2016 | Issued |
Array
(
[id] => 11443199
[patent_doc_number] => 20170044220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-16
[patent_title] => 'EXPRESSION OF TRIPLE-HELICAL COLLAGEN-LIKE PRODUCTS IN E.COLI'
[patent_app_type] => utility
[patent_app_number] => 15/168831
[patent_app_country] => US
[patent_app_date] => 2016-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 19126
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15168831
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/168831 | EXPRESSION OF TRIPLE-HELICAL COLLAGEN-LIKE PRODUCTS IN E.COLI | May 30, 2016 | Abandoned |
Array
(
[id] => 11067655
[patent_doc_number] => 20160264619
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-15
[patent_title] => 'PROCESS FOR PRODUCTION OF FIBRINOGEN'
[patent_app_type] => utility
[patent_app_number] => 15/164736
[patent_app_country] => US
[patent_app_date] => 2016-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4480
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15164736
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/164736 | Process for production of fibrinogen | May 24, 2016 | Issued |
Array
(
[id] => 11269257
[patent_doc_number] => 20160331804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-17
[patent_title] => 'SELECTIVELY TARGETED ANTIMICROBIAL PEPTIDES AND THE USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/163334
[patent_app_country] => US
[patent_app_date] => 2016-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 21201
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15163334
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/163334 | Selectively targeted antimicrobial peptides and the use thereof | May 23, 2016 | Issued |
Array
(
[id] => 16269111
[patent_doc_number] => 20200270598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => Liquid Enzyme Preparation and Preparation Method Thereof
[patent_app_type] => utility
[patent_app_number] => 15/780491
[patent_app_country] => US
[patent_app_date] => 2016-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12237
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15780491
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/780491 | Liquid Enzyme Preparation and Preparation Method Thereof | May 15, 2016 | Abandoned |
Array
(
[id] => 11270514
[patent_doc_number] => 20160333061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-17
[patent_title] => 'FUSION TAGS FOR PROTEIN EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 15/152908
[patent_app_country] => US
[patent_app_date] => 2016-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 27113
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15152908
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/152908 | Fusion tags for protein expression | May 11, 2016 | Issued |
Array
(
[id] => 12347448
[patent_doc_number] => 09951319
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-24
[patent_title] => Polypeptides having peroxygenase activity and polynucleotides encoding same
[patent_app_type] => utility
[patent_app_number] => 15/146457
[patent_app_country] => US
[patent_app_date] => 2016-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19433
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15146457
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/146457 | Polypeptides having peroxygenase activity and polynucleotides encoding same | May 3, 2016 | Issued |
Array
(
[id] => 11031562
[patent_doc_number] => 20160228518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-11
[patent_title] => 'Methods, Compounds, and Compositions For Treatment and Prophylaxis in the Respiratory Tract'
[patent_app_type] => utility
[patent_app_number] => 15/136751
[patent_app_country] => US
[patent_app_date] => 2016-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 29253
[patent_no_of_claims] => 115
[patent_no_of_ind_claims] => 57
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15136751
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/136751 | Methods, Compounds, and Compositions For Treatment and Prophylaxis in the Respiratory Tract | Apr 21, 2016 | Abandoned |
Array
(
[id] => 12509913
[patent_doc_number] => 10000758
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-19
[patent_title] => Microorganisms and methods for enhancing the availability of reducing equivalents in the presence of methanol, for producing methacrylic acid
[patent_app_type] => utility
[patent_app_number] => 15/133150
[patent_app_country] => US
[patent_app_date] => 2016-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 52779
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15133150
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/133150 | Microorganisms and methods for enhancing the availability of reducing equivalents in the presence of methanol, for producing methacrylic acid | Apr 18, 2016 | Issued |
Array
(
[id] => 11090712
[patent_doc_number] => 20160287677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-06
[patent_title] => 'BACTERIAL ANTI-PHAGE DEFENSE SYSTEMS'
[patent_app_type] => utility
[patent_app_number] => 15/131102
[patent_app_country] => US
[patent_app_date] => 2016-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 41144
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15131102
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/131102 | BACTERIAL ANTI-PHAGE DEFENSE SYSTEMS | Apr 17, 2016 | Abandoned |
Array
(
[id] => 15424447
[patent_doc_number] => 10545145
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-28
[patent_title] => Stochastic arrangement of reagents in clusters--STARC
[patent_app_type] => utility
[patent_app_number] => 15/099248
[patent_app_country] => US
[patent_app_date] => 2016-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 49
[patent_no_of_words] => 14180
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15099248
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/099248 | Stochastic arrangement of reagents in clusters--STARC | Apr 13, 2016 | Issued |
Array
(
[id] => 12326844
[patent_doc_number] => 09944934
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-17
[patent_title] => Inducible eukaryotic expression system
[patent_app_type] => utility
[patent_app_number] => 15/098291
[patent_app_country] => US
[patent_app_date] => 2016-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 15
[patent_no_of_words] => 11593
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 301
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15098291
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/098291 | Inducible eukaryotic expression system | Apr 12, 2016 | Issued |
Array
(
[id] => 11282676
[patent_doc_number] => 09498514
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-22
[patent_title] => 'Systems, compositions, and methods for transplantation and treating conditions'
[patent_app_type] => utility
[patent_app_number] => 15/081408
[patent_app_country] => US
[patent_app_date] => 2016-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 51
[patent_no_of_words] => 79334
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15081408
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/081408 | Systems, compositions, and methods for transplantation and treating conditions | Mar 24, 2016 | Issued |
Array
(
[id] => 10997719
[patent_doc_number] => 20160194665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-07
[patent_title] => 'METHODS AND COMPOSITIONS FOR INACTIVATING ALPHA 1,6 FUCOSYLTRANSFERASE (FUT8) GENE EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 15/080101
[patent_app_country] => US
[patent_app_date] => 2016-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 16460
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15080101
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/080101 | Methods and compositions for inactivating alpha 1,6 fucosyltransferase (FUT8) gene expression | Mar 23, 2016 | Issued |
Array
(
[id] => 12770728
[patent_doc_number] => 20180148744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-31
[patent_title] => BIOLOGICAL METHODS FOR PREPARING 3-HYDROXYPROPIONIC ACID
[patent_app_type] => utility
[patent_app_number] => 15/558863
[patent_app_country] => US
[patent_app_date] => 2016-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43646
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15558863
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/558863 | BIOLOGICAL METHODS FOR PREPARING 3-HYDROXYPROPIONIC ACID | Mar 17, 2016 | Abandoned |
Array
(
[id] => 12211048
[patent_doc_number] => 09907839
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-06
[patent_title] => 'Treatment of glycogen storage disease type II'
[patent_app_type] => utility
[patent_app_number] => 15/066211
[patent_app_country] => US
[patent_app_date] => 2016-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 6421
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15066211
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/066211 | Treatment of glycogen storage disease type II | Mar 9, 2016 | Issued |
Array
(
[id] => 11290766
[patent_doc_number] => 20160340698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-24
[patent_title] => 'GENETICALLY ENGINEERED YEAST CELL HAVING INCREASED NADPH PRODUCTION, METHOD OF INCREASING NADPH LEVEL IN YEAST CELL, METHOD OF PREPARING YEAST CELL, AND METHOD OF PRODUCING LACTATE USING YEAST CELL'
[patent_app_type] => utility
[patent_app_number] => 15/066775
[patent_app_country] => US
[patent_app_date] => 2016-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 18099
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15066775
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/066775 | Genetically engineered yeast cell having increased NADPH production, method of increasing NADPH level in yeast cell, method of preparing yeast cell, and method of producing lactate using yeast cell | Mar 9, 2016 | Issued |
Array
(
[id] => 12286201
[patent_doc_number] => 09932389
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-03
[patent_title] => Silk-elastin like protein polymers for embolization and chemoembolization to treat cancer
[patent_app_type] => utility
[patent_app_number] => 15/064142
[patent_app_country] => US
[patent_app_date] => 2016-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 14
[patent_no_of_words] => 5064
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15064142
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/064142 | Silk-elastin like protein polymers for embolization and chemoembolization to treat cancer | Mar 7, 2016 | Issued |